Latest Mild cognitive impairment Stories
DALLAS, April 16, 2015 /PRNewswire/ -- RnRMarketResearch.com adds 2015 EpiCast Report on Alzheimer's Disease - Epidemiology Forecast to 2023 of 82 pages to the Alzheimer
Alzheimer's Association and American College of Radiology Lead Four-Year Trial to Inform Medicare Coverage of Brain Amyloid Imaging CHICAGO, April 16, 2015 /PRNewswire-USNewswire/ -- A new
First and only clinical trial to reduce hippocampal overactivity during aMCI, the pre-dementia stage of Alzheimer's disease BALTIMORE, March 11, 2015 /PRNewswire/ --
Some people over the age of 80 demonstrate such sharp memories that scientists are eager to know just what it is that sets them apart from other people their age. Known as “SuperAgers,” this “cognitively elite” group displays memory capabilities similar to healthy people decades younger, and understanding the inner-workings of their brains could help to treat seniors who are less fortunate.
AGB101 could be the first drug to modify progression of amnestic mild cognitive impairment (aMCI) in patients at a high-risk for progressing to Alzheimer's dementia NEW YORK, Jan.
Phase 3-ready AGB101 designed to address aMCI, the pre-dementia stage of Alzheimer's Disease BALTIMORE, Jan.
WINSTON-SALEM, N.C., Jan.
According to neuropsychologist Dr.
- In costermongers' slang, a cheap red-skinned apple, which is rubbed hard with a cloth to give it the appearance and feeling of an apple of superior quality.